NO20003179L - Farmasøytisk sammensetning for Õ antagonisere CCR5 som innbefatter anilid-derivat - Google Patents
Farmasøytisk sammensetning for Õ antagonisere CCR5 som innbefatter anilid-derivatInfo
- Publication number
- NO20003179L NO20003179L NO20003179A NO20003179A NO20003179L NO 20003179 L NO20003179 L NO 20003179L NO 20003179 A NO20003179 A NO 20003179A NO 20003179 A NO20003179 A NO 20003179A NO 20003179 L NO20003179 L NO 20003179L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- pharmaceutical composition
- ring
- anilide derivative
- antagonizing ccr5
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35148097 | 1997-12-19 | ||
JP21887598 | 1998-08-03 | ||
JP23438898 | 1998-08-20 | ||
PCT/JP1998/005708 WO1999032100A2 (en) | 1997-12-19 | 1998-12-17 | Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003179D0 NO20003179D0 (no) | 2000-06-19 |
NO20003179L true NO20003179L (no) | 2000-06-19 |
Family
ID=27330200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003179A NO20003179L (no) | 1997-12-19 | 2000-06-19 | Farmasøytisk sammensetning for Õ antagonisere CCR5 som innbefatter anilid-derivat |
Country Status (12)
Country | Link |
---|---|
US (2) | US6172061B1 (ko) |
EP (1) | EP1039899A2 (ko) |
JP (1) | JP2000128782A (ko) |
KR (1) | KR20010032841A (ko) |
CN (1) | CN1282243A (ko) |
AU (1) | AU748064B2 (ko) |
BR (1) | BR9813691A (ko) |
CA (1) | CA2304959A1 (ko) |
HU (1) | HUP0100199A2 (ko) |
ID (1) | ID29994A (ko) |
NO (1) | NO20003179L (ko) |
WO (1) | WO1999032100A2 (ko) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
FR2746101B1 (fr) * | 1996-03-14 | 1998-04-30 | Composes bicycliques-aromatiques | |
EP1100495A4 (en) * | 1998-07-28 | 2002-09-25 | Smithkline Beecham Corp | PROPENAMIDES AS CCR5 MODULATORS |
CA2337307A1 (en) * | 1998-08-20 | 2000-03-02 | Osamu Nishimura | Quaternary ammonium salts and their use |
WO2000021916A1 (fr) * | 1998-10-15 | 2000-04-20 | Takeda Chemical Industries, Ltd. | Procede de preparation de derives d'amine |
US6635278B1 (en) * | 1998-12-15 | 2003-10-21 | Gilead Sciences, Inc. | Pharmaceutical formulations |
EP1140896A1 (en) * | 1998-12-21 | 2001-10-10 | Takeda Chemical Industries, Ltd. | Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5 |
HUP0200761A3 (en) | 1999-03-24 | 2003-05-28 | Anormed Inc Langley | Chemokine receptor binding heterocyclic compounds, pharmaceutical compositions containing them and their use |
US6750348B1 (en) | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
EP1182195A4 (en) | 1999-05-07 | 2003-03-26 | Takeda Chemical Industries Ltd | CYCLIC CONNECTIONS AND APPLICATIONS THEREOF |
CA2373464A1 (en) | 1999-05-18 | 2000-11-23 | Tomomi Ikemoto | Process for the preparation of 2,3-dihydrothiepine derivatives |
US6936602B1 (en) | 1999-06-16 | 2005-08-30 | Takeda Chemical Industries, Ltd. | Benzazepine derivatives, process for the preparation of the same and uses thereof |
WO2001017971A1 (fr) * | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Procede de preparation de derives 2,3-dihydroazepine |
CA2384145A1 (en) * | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Process for the preparation of 2,3-dihydroazepine compounds |
GB2371622A (en) * | 1999-09-23 | 2002-07-31 | Isis Innovation | Susceptibility gene for inflammatory bowel disease |
EP1236476A1 (en) * | 1999-12-10 | 2002-09-04 | Takeda Chemical Industries, Ltd. | Medicinal compositions for oral use |
KR20030005202A (ko) * | 2000-02-21 | 2003-01-17 | 다케다 야쿠힌 고교 가부시키가이샤 | 환상 화합물의 제조 방법 |
KR20030011805A (ko) | 2000-03-30 | 2003-02-11 | 브리스톨-마이어스스퀴브컴파니 | 스타부딘을 함유하는 서방성 비들렛 |
US6835731B2 (en) * | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
EP1343796A4 (en) * | 2000-10-23 | 2005-01-12 | Smithkline Beecham Corp | COMPOUNDS AND METHODS |
WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
EP2206702B1 (en) | 2001-08-08 | 2011-12-28 | Tobira Therapeutics, Inc. | Bicyclic compound, production and use thereof |
WO2003014110A1 (fr) * | 2001-08-08 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Derive de benzazepine, son procede de preparation et d'utilisation |
CN101353324A (zh) | 2001-09-12 | 2009-01-28 | 阿诺麦德股份有限公司 | 对映体纯的氨基取代稠合双环的合成 |
WO2003090748A1 (fr) * | 2002-04-24 | 2003-11-06 | Takeda Pharmaceutical Compay Limited. | Utilisation de composes a antagonisme anti-ccr |
SI1569907T1 (sl) * | 2002-12-13 | 2016-06-30 | Ym Biosciences Australia Pty Ltd | Na nikotinamidu osnovani kinazni inhibitorji |
EP1593680A4 (en) * | 2003-02-07 | 2008-05-07 | Takeda Pharmaceutical | PYRIDINE DERIVATIVES WITH CONDENSED RING, PROCESS FOR THEIR PREPARATION AND USE |
US20060160864A1 (en) * | 2003-02-07 | 2006-07-20 | Mitsuru Shiraishi | Acrylamide derivative, process for producing the same, and use |
CA2517888C (en) | 2003-03-14 | 2012-05-01 | Ono Pharmaceutical Co., Ltd. | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
CN101333186A (zh) * | 2003-03-14 | 2008-12-31 | 小野药品工业株式会社 | 含氮杂环衍生物以及包含所述化合物作为活性成分的药物 |
JP4710606B2 (ja) | 2003-04-18 | 2011-06-29 | 小野薬品工業株式会社 | スピロピペリジン化合物およびその医薬用途 |
GB0403038D0 (en) | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
AU2005267385B2 (en) * | 2004-06-25 | 2011-11-10 | Janssen Pharmaceutica N.V. | Quaternary salt CCR2 antagonists |
TWI400232B (zh) | 2004-09-13 | 2013-07-01 | Ono Pharmaceutical Co | 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑 |
US20110052612A1 (en) | 2005-05-31 | 2011-03-03 | Ono Pharmaceutical Co., Ltd. | Spiropiperidine compound and medicinal use thereof |
ES2427989T3 (es) | 2005-10-28 | 2013-11-05 | Ono Pharmaceutical Co., Ltd. | Compuesto que contiene un grupo básico y uso del mismo |
PL1961744T3 (pl) | 2005-11-18 | 2013-09-30 | Ono Pharmaceutical Co | Związek zawierający grupę zasadową oraz jego zastosowanie |
CA2644368A1 (en) | 2006-03-10 | 2007-09-20 | Ono Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
EP2004238A2 (en) * | 2006-03-21 | 2008-12-24 | Amylin Pharmaceuticals, Inc. | Peptide-peptidase inhibitor conjugates and methods of using same |
JP5257068B2 (ja) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | 保護されていてもよい酸性基を含有する化合物およびその用途 |
WO2008016006A1 (en) | 2006-07-31 | 2008-02-07 | Ono Pharmaceutical Co., Ltd. | Compound having cyclic group bound thereto through spiro binding and use thereof |
US20080108586A1 (en) * | 2006-09-06 | 2008-05-08 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
PE20081785A1 (es) * | 2007-02-19 | 2009-01-12 | Novartis Ag | Derivados de ciclohexil-amida del acido aril carboxilico |
US8093428B2 (en) * | 2007-10-26 | 2012-01-10 | Janssen Pharmaceutica N.V. | Synthesis of quaternary salt compounds |
US8168829B2 (en) * | 2007-10-26 | 2012-05-01 | Janssen Pharmaceutica N.V. | Synthesis of quaternary salt compounds |
CN102796075B (zh) * | 2008-01-11 | 2014-03-12 | 中国人民解放军军事医学科学院毒物药物研究所 | 苯并环庚烯类衍生物、其制备方法及医药用途 |
CN101481323B (zh) * | 2008-01-11 | 2013-11-20 | 中国人民解放军军事医学科学院毒物药物研究所 | 苯并环庚烯类衍生物、其制备方法及医药用途 |
WO2010054215A1 (en) * | 2008-11-06 | 2010-05-14 | Ventirx Pharmaceuticals, Inc. | Methods of synthesis of benzazepine derivatives |
WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
US20140271680A1 (en) | 2011-08-12 | 2014-09-18 | Universite Paris-Est Creteil Val De Marne | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
WO2016019587A1 (en) * | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | [7, 6]-fused bicyclic antidiabetic compounds |
MX2017008280A (es) | 2014-12-23 | 2017-12-07 | Tobira Therapeutics Inc | Proceso para elaborar cenicriviroc y analogos relacionados. |
WO2017106332A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
CN109069426B (zh) | 2015-12-14 | 2021-10-29 | X4 制药有限公司 | 治疗癌症的方法 |
US10610527B2 (en) | 2015-12-22 | 2020-04-07 | X4 Pharmaceuticals, Inc. | Methods for treating immunodeficiency disease |
JP2019510785A (ja) | 2016-04-08 | 2019-04-18 | エックス4 ファーマシューティカルズ, インコーポレイテッド | 癌を処置する方法 |
CA3027495A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
KR20190039087A (ko) | 2016-06-21 | 2019-04-10 | 토비라 쎄라퓨틱스, 인크. | 정제된 세니크리비록 및 세니크리비록을 제조하기 위한 정제된 중간체 |
CA3027500A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
JP7054529B2 (ja) | 2016-06-21 | 2022-04-14 | エックス4 ファーマシューティカルズ, インコーポレイテッド | Cxcr4阻害剤およびその使用 |
CN110167550A (zh) | 2016-08-31 | 2019-08-23 | 妥必徕疗治公司 | 西克里维罗甲磺酸盐的固体形式及其制备方法 |
WO2018103757A1 (zh) * | 2016-12-09 | 2018-06-14 | 广东众生药业股份有限公司 | 作为ccr2/ccr5受体拮抗剂的联苯化合物 |
US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
CN113735904B (zh) * | 2021-09-17 | 2023-10-24 | 南京自一界科技研发有限公司 | 一种润滑添加剂的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151744A (zh) | 1994-07-04 | 1997-06-11 | 武田药品工业株式会社 | 膦酸化合物及其制备和应用 |
KR20010032643A (ko) * | 1997-12-19 | 2001-04-25 | 다케다 야쿠힌 고교 가부시키가이샤 | 아닐리드 유도체, 그의 제조 및 용도 |
-
1998
- 1998-12-17 BR BR9813691-7A patent/BR9813691A/pt not_active IP Right Cessation
- 1998-12-17 CA CA002304959A patent/CA2304959A1/en not_active Abandoned
- 1998-12-17 AU AU16831/99A patent/AU748064B2/en not_active Withdrawn - After Issue
- 1998-12-17 US US09/213,377 patent/US6172061B1/en not_active Expired - Fee Related
- 1998-12-17 HU HU0100199A patent/HUP0100199A2/hu unknown
- 1998-12-17 KR KR1020007006167A patent/KR20010032841A/ko not_active Application Discontinuation
- 1998-12-17 CN CN98811942A patent/CN1282243A/zh active Pending
- 1998-12-17 ID IDP981644A patent/ID29994A/id unknown
- 1998-12-17 WO PCT/JP1998/005708 patent/WO1999032100A2/en not_active Application Discontinuation
- 1998-12-17 EP EP98961384A patent/EP1039899A2/en not_active Withdrawn
- 1998-12-18 JP JP10360820A patent/JP2000128782A/ja not_active Withdrawn
-
2000
- 2000-06-19 NO NO20003179A patent/NO20003179L/no not_active Application Discontinuation
- 2000-09-13 US US09/661,320 patent/US6268354B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1999032100A3 (en) | 1999-09-10 |
WO1999032100A2 (en) | 1999-07-01 |
NO20003179D0 (no) | 2000-06-19 |
CA2304959A1 (en) | 1999-07-01 |
ID29994A (id) | 2001-10-25 |
EP1039899A2 (en) | 2000-10-04 |
US6172061B1 (en) | 2001-01-09 |
JP2000128782A (ja) | 2000-05-09 |
US6268354B1 (en) | 2001-07-31 |
AU1683199A (en) | 1999-07-12 |
AU748064B2 (en) | 2002-05-30 |
CN1282243A (zh) | 2001-01-31 |
KR20010032841A (ko) | 2001-04-25 |
BR9813691A (pt) | 2000-10-10 |
HUP0100199A2 (hu) | 2001-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003179L (no) | Farmasøytisk sammensetning for Õ antagonisere CCR5 som innbefatter anilid-derivat | |
NO20003133L (no) | Anilid-derivat, fremstilling og anvendelse derav | |
BR0207809A (pt) | Compostos heteroarila contendo nitrogênio possuindo atividade inibidora contra integrase de hiv | |
NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
NO307047B1 (no) | Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav | |
NO932620L (no) | Amindiol-proteaseinhibitorer | |
NO970512L (no) | Nye heteroaryl-oksazolidinoner | |
WO1999041237A8 (en) | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity | |
MXPA02012314A (es) | Compuestos de 1,2-dihidropiridina, metodo de fabricacion y utilizacion de los mismos. | |
DK0650961T3 (da) | Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler. | |
NO180583C (no) | Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
TR199800924T2 (xx) | Quinoline t�revleri. | |
CA2260213A1 (en) | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists | |
CA2119647A1 (en) | Heteroaryl Amines as Novel Acetylcholinesterase Inhibitors | |
CA2093077A1 (en) | 2- and 3-amino and azido derivatives of 1,5-iminosugars | |
DE69427517T2 (de) | Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz | |
NO952205L (no) | Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter | |
CA2093076A1 (en) | 2- and 3-amino and azido derivatives of 1,5-iminosugars | |
DK492288D0 (da) | Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne | |
YU69699A (sh) | Derivati aril karbonske kiseline i tetrazola | |
MX9707461A (es) | Heterociclos nitrogenados de ciclohexilamino y ciclohexilalcoxi, metodos para preparar los mismos y su uso como agentes de control de pestes y fungicidas. | |
WO2001060822A8 (fr) | Derives d'aminoacides et leur utilisation en tant qu'inhibiteurs de la nep, l'ace et l'ece | |
NO961168L (no) | Nye uretanholdige aminosteroid forbindelser | |
EP1283208A4 (en) | NEW BENZOFURAN DERIVATIVES | |
NO984921L (no) | Tienopyridinderivater og deres anvendelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |